Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strategies to optimize adult access to pneumococcal vaccination
RBR-7ymz2qPhase 4Completed
- Sponsor
- Universidade Estadual Paulista
- Start
- Feb 2018
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease and pneumonia (2 arms), sponsored by Universidade Estadual Paulista. Started Feb 2018; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal diseasepneumonia
Beyond the preview
Go deeper on RBR-7ymz2q.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7ymz2q.